Back to search

Article

Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumor

2018-12-30

Abstract excerpt

Wilms tumor (WT) is the most common childhood kidney cancer. To improve risk stratification and identify novel therapeutic targets for patients with WT, we used high-resolution mass spectrometry proteomics to identify urine tumor markers associated with WT relapse. We determined urine proteomes at diagnosis of 49 patients with WT, non-WT renal tumors, and age-matched controls, leading to the quantitation of 6,520...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
20a32cd4-0885-57f5-a507-3155188f265e
DOI
10.1101/508754
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prohibitin is a prognostic marker of relapse and therapeutic target to block chemotherapy resistance in Wilms tumorDOI 10.1101/508754
Select a neighboring publication to make it the new centre.